Equities researchers at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright lifted their target price on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Stock Report on SenesTech
SenesTech Stock Up 6.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- 3 Warren Buffett Stocks to Buy Now
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- Differences Between Momentum Investing and Long Term Investing
- Top 3 ETFs to Hedge Against Inflation in 2025
- What Investors Need to Know About Upcoming IPOs
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.